Howerton Michael

Avg. Two Year Performance

No purchase track record
(58%) Avg. Sale Return
(26%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(3%)(4%)(7%)(10%)(58%)
Sale Success Rate3 of 53 of 53 of 52 of 51 of 5

Imclone Systems Inc.

Drugs » Biotechnology

SVP, CHIEF FINANCIAL OFFICER:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--